Thermo Fisher Scientific Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2007 | $1.48B | $1.31B | $175.5M | $51.1M |
| FY2008 | $1.42B | $1.16B | $264.4M | $57.1M |
| FY2009 | $1.66B | $1.46B | $200.0M | $67.0M |
| FY2010 | $1.50B | $1.25B | $245.4M | $81.6M |
| FY2011 | $1.69B | $1.43B | $260.9M | $80.0M |
| FY2012 | $2.04B | $1.72B | $315.1M | $78.2M |
| FY2013 | $2.01B | $1.73B | $282.4M | $90.9M |
| FY2014 | $2.62B | $2.19B | $427.6M | $117.1M |
| FY2015 | $2.94B | $2.52B | $423.0M | $125.0M |
| FY2016 | $3.26B | $2.81B | $444.0M | $133.0M |
| FY2017 | $4.01B | $3.50B | $508.0M | $159.0M |
| FY2018 | $4.54B | $3.79B | $758.0M | $181.0M |
| FY2019 | $4.97B | $4.05B | $926.0M | $181.0M |
| FY2020 | $8.29B | $6.82B | $1.47B | $196.0M |
| FY2021 | $9.31B | $6.79B | $2.52B | $230.0M |
| FY2022 | $9.15B | $6.91B | $2.24B | $307.0M |
| FY2023 | $8.41B | $6.93B | $1.48B | $278.0M |
| FY2024 | $8.67B | $7.27B | $1.40B | $301.0M |
| FY2025 | $7.82B | $6.29B | $1.53B | $310.0M |